P355
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaDabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by SurgeryLung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerAdrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic SyndromeEvaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502Psychological Effects of Bone Marrow Transplants in ChildrenClofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaRandomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed NeuroblastomaAssessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionCaspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantPediatric Philadelphia Positive Acute Lymphoblastic LeukemiaBortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaRuxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid LeukemiaGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersTreating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseComparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaGenetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentThe EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLLong-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group StudiesGut Microbial Transplantation in Pediatric Inflammatory Bowel DiseasesA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive MedulloblastomaVorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaCombination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaPre-Symptomatic Study of Intravenous AVXS-101 in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelStandardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed NeuroblastomaHypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerPembrolizumab in Treating Patients With Locally Advanced Bladder CancerAn Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic ChemotherapyFirstline Pembrolizumab Alone or in Combination With Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients With Stage IV Non-squamous Non-small Cell Lung CancerBlinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed, Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma
P6153
Healthy Weight for TeensThe Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenRCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI StudiesStudy of Fluid Collection of the Chest in Children With PneumoniaStudy of the Use of Coated Venous Catheters in the Critically Ill ChildThe Effectiveness of Oral Dexamethasone for Acute BronchiolitisPediatric Obesity Weight Evaluation Registry (POWER) Study
P767
Q58407636-AB1DA29E-04BD-406D-BE99-D7F373789D6CQ58845627-A2473062-1185-4516-BB2D-6871D4A84B95Q61862239-55661527-583B-49D2-9994-547A2D4B6FEDQ61864729-D033D2AC-A03D-44C4-BC9A-57544514D1E3Q61865593-D414A9F9-B263-4FD1-9FC7-5680DAC64DEBQ61894261-5EEC37EC-1DD1-48C6-809E-9A8ED71BDB6EQ61906994-988FEE5D-A14D-4FDB-AB87-1AF430D20CE3Q61914384-F82A974F-A443-45E6-9653-F5B193A84ACCQ61932947-340141F7-BC9C-45CA-B78A-5E93BEE29A40Q61933567-7776573C-6B01-44EA-AD6C-B57293A4E867Q61936459-C7ADAE85-7C6A-4280-8E5E-80AC605BBE4BQ61957081-08E22B0A-8C18-4578-8476-B7032A5D3DF0Q61957392-2C36A8F3-E426-4CED-B480-CA05FB6754C1Q61957400-F0CFD389-B05E-400F-8B4E-FAF595436C66Q61965726-B8239728-2E0B-43D5-B7C3-84DAAB6CA84AQ61980425-AF923296-65CC-41E8-B913-4ED2EBB0E4D0Q61980943-69E5C532-272C-454E-9942-DF9B48A51023Q62025050-8C32FAA3-8791-4CD2-B58B-D5E88E763586Q62031551-A92E0243-2514-44D1-BA43-8D2C7A0A5256Q62105638-717368AE-0F43-47AC-B24D-C056D3C4A85CQ62110645-C9FD98B4-5ED9-4A3C-947A-D702AA27EC8DQ62111100-D1E34106-B65F-4220-8DD1-9EC7286D89DFQ62815257-CDC3D7B9-482B-4706-88B8-E76EDD1D7BFDQ62817334-ABD9E2D0-63AC-45DA-AF88-31210D25ADA6Q62821141-22DC40F2-78B3-4E34-AABC-D453AF4BACA0Q63063289-90941BF0-E9EB-4B62-8D31-534CFDCCCF66Q63316567-32DE4316-FB2E-45E1-B846-548A9E8C6723Q63334484-410CE7BF-F2D1-49EA-A05C-5A9AD3DF95C1Q63336838-DDE55CF4-BFAC-452B-9C69-88D66F74364DQ63340651-51D1D095-931E-4294-9948-BEA13A4A5E11Q63341046-AE01F98E-1735-4982-AD21-FC4486060606Q63397869-AFD85A16-D403-4080-8F52-3D7EDA16DCABQ63403966-4F076A6E-656B-492B-A212-8BE56A701D77Q63404450-2142DFEE-6858-4D8C-82B0-5CD6BC5F45C3Q63405187-2D161C1C-9DC1-4B63-A95B-7235345C9065Q63572983-A9892852-229A-4B5E-B20C-16872F68BF10Q63573491-6046F404-F7E2-4863-AC1E-7AC013EA8160Q63573996-24A344A7-A350-47E7-8DB1-04A7797D71CAQ63575200-01088046-7E16-4038-ACCF-AFBD46A3FE4BQ63578202-58F582EA-736A-4EAF-BC6F-660ADA523486
P6153
Q64187180-339D91A6-CEE7-422D-95F8-463C91CCA23AQ64677862-3CFD72A0-FD20-4E97-AA66-DD56A815486CQ65469906-27927A43-054B-46A6-A14B-C7525DC98F4CQ65544910-E07D32F9-ED8E-4970-A085-2C61C1B1281FQ65544912-807FAA47-F6D7-42D7-AED1-B9A6825720E0Q66032846-274226F8-0C36-4CBB-BEDE-FF542FB36CBBQ67134305-71D16592-5D98-4E89-B454-32B3931EE5C7
P767
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in Michigan, United States
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in Michigan, Verenigde Staten van Amerika
@nl
בית חולים בארצות הברית
@he
name
Helen DeVos Children's Hospital
@en
type
label
Helen DeVos Children's Hospital
@en
prefLabel
Helen DeVos Children's Hospital
@en
P131
P213
0000 0004 0450 6121
P2427
grid.413656.3
P3417
Helen-DeVos-Childrens-Hospital
P3500
P373
Helen DeVos Children's Hospital
P571
1970-01-01T00:00:00Z
P625
Point (-85.6658 42.9705)